Issue 5, 2016

Chenopodium album metabolites act as dual topoisomerase inhibitors and induce apoptosis in the MCF7 cell line

Abstract

Desgalactotigonin (DGT) and oleanolic acid 3-O-β-D-glucuronide (OAG) were isolated from Chenopodium album seeds, characterized using spectral analysis and evaluated for cytotoxic activity against various cancer cell lines. DGT and OAG induced apoptosis in a human breast cancer cell line (MCF-7) and were found to effectively inhibit human topoisomerases I and II in vitro. The study of the mode of enzyme inhibition revealed that both acted as catalytic inhibitors. IC50 values for DGT and OAG on MCF-7 cells were found to be 8.27 μM and 11.33 μM respectively. Using FACS and western blot analysis, the compounds were observed to block the cell cycle at S phase. Activation of caspases 7 and 9 suggested that caspase pathways were involved in inducing apoptosis.

Graphical abstract: Chenopodium album metabolites act as dual topoisomerase inhibitors and induce apoptosis in the MCF7 cell line

Supplementary files

Article information

Article type
Research Article
Submitted
02 Nov 2015
Accepted
02 Feb 2016
First published
18 Feb 2016

Med. Chem. Commun., 2016,7, 837-844

Chenopodium album metabolites act as dual topoisomerase inhibitors and induce apoptosis in the MCF7 cell line

D. Chakraborty, C. K. Jain, A. Maity, S. Ghosh, S. R. Choudhury, T. Jha, H. K. Majumder and N. B. Mondal, Med. Chem. Commun., 2016, 7, 837 DOI: 10.1039/C5MD00502G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements